Back to search

Peptide record

TPDB42891

#2(D33-N52) Anticancer standard
30 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB42891
#2(D33-N52)
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 30-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
RRRRRRRRGGDRDYKKFWAGLQGLTIYFYN
Physicochemical Analysis
C172H270N62O41
CEHMPSV
R
3862.43
12.12
11
2
10
+9
4.38
-1.663
42.33
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
9970
258.13
6
Residue Composition
number
1
A
9
R
1
N
2
D
0
C
0
E
1
Q
4
G
0
H
1
I
2
L
2
K
0
M
2
F
0
P
0
S
1
T
1
W
3
Y
0
V
Amino Acid Distribution
A: 1 R: 9 N: 1 D: 2 C: 0 E: 0 Q: 1 G: 4 H: 0 I: 1 L: 2 K: 2 M: 0 F: 2 P: 0 S: 0 T: 1 W: 1 Y: 3 V: 0
Chemical Descriptors
30
C172H270N62O41
3862.43
12.12
+9
4.38
-1.663
Free
L
Linear
Free
Anticancer
STAP-2 PH domain–derived peptide
Evidence Records 2 records
Evidence 1 Activity

Activity

Graph figure 1-B
Anticancer

Target

Liver Cancer
DU-145
Liver

Assay & Model

CellTiter-Glo assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

Graph figure 1-B
Anticancer

Target

Breast Cancer
MCF-7
Breast

Assay & Model

CellTiter-Glo assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023